{"id":"W4220931859","doi":"10.1007/s10549-021-06417-y","title":"Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health","keywords":"Epirubicin; Medicine; Breast cancer; Internal medicine; Placebo; Cyclophosphamide; Clinical endpoint; Chemotherapy; Oncology; Cancer; Surgery; Clinical trial; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002617909,0.001732849,0.002486808,0.000333404,0.0004951709,0.0009269794,0.0009607706,0.002553203,0.009127573],"category_scores_gemma":[0.002878,0.0005058739,0.001924871,0.0003682086,0.001317153,0.0008721286,0.000368793,0.004549594,0.001501004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006366128,"about_ca_system_score_gemma":0.001380352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001080566,"about_ca_topic_score_gemma":0.002584974,"domain_scores_codex":[0.9992632,0.0004861325,0.0000298664,0.00008489876,0.00003615882,0.0000996298],"domain_scores_gemma":[0.9977158,0.0008224928,0.000329015,0.0002975401,0.0001064865,0.0007287164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9647176,0.01059175,0.0005922935,0.0002853539,0.0006875565,0.00003114394,0.00005980779,0.0005699353,0.003350527,0.0001342877,0.001547646,0.01743208],"study_design_scores_gemma":[0.8580129,0.1352042,0.00327982,0.00004162101,0.0005118666,0.000049029,0.00003799878,0.0002788203,0.0005905812,0.0003079795,0.001667158,0.00001821509],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760887,0.00576315,0.001109118,0.003252507,0.00106563,0.003469336,0.003154951,0.000174165,0.00592247],"genre_scores_gemma":[0.9699201,0.002866069,0.003333928,0.003740837,0.0008050053,0.003274546,0.004711903,0.00006513025,0.01128248],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009127573,"threshold_uncertainty_score":0.0305348,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.086597028550857,"score_gpt":0.3949531656894934,"score_spread":0.3083561371386364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}